Equity Details
Price & Market Data
Price: $1.77
Daily Change: -$0.06 / 3.39%
Daily Range: $1.77 - $2.14
Market Cap: $12,744,685
Daily Volume: 74,908
Performance Metrics
1 Week: 8.59%
1 Month: 4.12%
3 Months: 13.46%
6 Months: -32.95%
1 Year: -64.31%
YTD: 7.27%
About Chemomab Therapeutics Ltd. (CMMB)
A complete market overview for Chemomab Therapeutics Ltd. (CMMB). The stock is at 1.77, with a daily change of -$0.06 / 3.39%. Market cap: 12,744,685. Delve into its YTD and 3-month performance.
Company Details
Employees: 12
Sector: Health technology
Industry: Biotechnology
Country: Israel
Details
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.